227 related articles for article (PubMed ID: 22459156)
1. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
Saugel B; Nowack MC; Hapfelmeier A; Umgelter A; Schultheiss C; Thies P; Phillip V; Eyer F; Schmid RM; Huber W
J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
[TBL] [Abstract][Full Text] [Related]
2. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients.
Ocampos-Martinez E; Penaccini L; Scolletta S; Abdelhadii A; Devigili A; Cianferoni S; de Backer D; Jacobs F; Cotton F; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2012 Apr; 39(4):332-7. PubMed ID: 22333933
[TBL] [Abstract][Full Text] [Related]
3. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
[TBL] [Abstract][Full Text] [Related]
4. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy.
Covajes C; Scolletta S; Penaccini L; Ocampos-Martinez E; Abdelhadii A; Beumier M; Jacobs F; de Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2013 Mar; 41(3):261-6. PubMed ID: 23312601
[TBL] [Abstract][Full Text] [Related]
6. Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects.
Ampe E; Delaere B; Hecq JD; Tulkens PM; Glupczynski Y
Int J Antimicrob Agents; 2013 May; 41(5):439-46. PubMed ID: 23523733
[TBL] [Abstract][Full Text] [Related]
7. A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
Jeurissen A; Sluyts I; Rutsaert R
Int J Antimicrob Agents; 2011 Jan; 37(1):75-7. PubMed ID: 21074374
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
9. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
van Maarseveen EM; Gipmans S; Vasbinder E; Petjak M; van Zanten AR
Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion.
De Waele JJ; Danneels I; Depuydt P; Decruyenaere J; Bourgeois M; Hoste E
Int J Antimicrob Agents; 2013 May; 41(5):434-8. PubMed ID: 23410793
[TBL] [Abstract][Full Text] [Related]
11. Augmented renal clearance in septic patients and implications for vancomycin optimisation.
Baptista JP; Sousa E; Martins PJ; Pimentel JM
Int J Antimicrob Agents; 2012 May; 39(5):420-3. PubMed ID: 22386742
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia.
Hochart C; Berthon C; Corm S; Gay J; Cliquennois M; Tricot S; Alfandari S
Med Mal Infect; 2011 Dec; 41(12):652-6. PubMed ID: 22056376
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
Waineo MF; Kuhn TC; Brown DL
J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
[TBL] [Abstract][Full Text] [Related]
14. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
15. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application.
Tafelski S; Nachtigall I; Troeger U; Deja M; Krannich A; Günzel K; Spies C;
J Infect Public Health; 2015; 8(4):355-63. PubMed ID: 25794497
[TBL] [Abstract][Full Text] [Related]
16. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
Plan O; Cambonie G; Barbotte E; Meyer P; Devine C; Milesi C; Pidoux O; Badr M; Picaud JC
Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a dosing regimen for continuous vancomycin infusion in critically ill patients: an observational study in intensive care unit patients.
Saugel B; Gramm C; Wagner JY; Messer M; Lahmer T; Meidert AS; Schmid RM; Huber W
J Crit Care; 2014 Jun; 29(3):351-5. PubMed ID: 24456810
[TBL] [Abstract][Full Text] [Related]
18. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
[TBL] [Abstract][Full Text] [Related]
19. Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients.
Hong LT; Goolsby TA; Sherman DS; Mueller SW; Reynolds P; Cava L; Neumann R; Kiser TH
J Crit Care; 2015 Oct; 30(5):1153.e1-6. PubMed ID: 26239323
[TBL] [Abstract][Full Text] [Related]
20. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.
Beumier M; Roberts JA; Kabtouri H; Hites M; Cotton F; Wolff F; Lipman J; Jacobs F; Vincent JL; Taccone FS
J Antimicrob Chemother; 2013 Dec; 68(12):2859-65. PubMed ID: 23800905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]